baber/WOPTO huggingface dataset:
Patent NZ-329363-A (NZ)
Title: 3-[2-oxo-pyrrolidinyl-3-ylidene]methylene substituted 7-[2-(5-amino-[1,2,4]thiadiazol-3-yl)2-hydroxyimino-acetylamino ]-cephalosporin derivatives and medicaments
Inventor: ANGEHRN PETER
IPC: C07D501/24
Filed: 1997-12-09
Abstract: The present invention relates to cephalosporin derivatives of the general formula <CHEM>  wherein   X   is CH or N; R<1>   is hydrogen or cyclopentyl; R<2>   is a group of formula <CHEM>   R<3>   is hydrogen, an alkalimetal ion or a tertiary ammonium group; R<4>   is hydrogen, an amino protecting group, pyrrolidin-2-ylmethyl, azetidin-3-ylmethyl, iminomethyl, 1-carbamimidoyl; R<5>   is hydrogen, dialkylcarbamoyl,  omega -hydroxyalkyl,  omega -aminoalkyl, pyridinium-1-ylmethyl, 1-hydroxy-3-aminomethyl-propyl or (hydroxy)-(pyrrolidin-2-yl)methyl; R<6>   is hydrogen, trifluoromethyl or hydroxy; and R<7>   is alkyl,  omega -hydroxy-alkyl, cycloalkyl, 3-pyrrolidinyl, 3-azetidinyl, iminomethyl or 1-carbamimidoyl; as well as readily hydrolyzable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts; the invention is further concerned with the manufacture of compounds of formula I; with their use as pharmaceutically active substances, particularly for the treatment and prophylaxis of infectious diseases, and with pharmaceutical preparations containing a compound of formula I for the treatment and prophylaxis of infectious diseases.
Patent NZ-331018-A (NZ)
Title: Twin coupler for optical amplifier, couplers fused and tapered by different amounts
Inventor: FRANZOSO FEDERICO
IPC: H04B10/2581
Filed: 1998-07-17
Abstract: An optical amplifier system includes a multimode pump laser 3500.  Energy from laser 3500 is coupled into a signal fibre 3100 at two couplers 3600 and 3700.  The second coupler 3700 uses energy not transferred into fibre 3100 by first coupler 3600.  The amount of energy transferred by the second coupler is dependent on the amount of energy transferred by the first coupler.  The couplers are formed by fusion and tapering operations, these operations being carried out while a multimode laser is coupled to the pump fibre.  The fusion and tapering operations are terminated when it is determined that maximum multimode optical signal transfer is obtained.
Patent NZ-332052-A (NZ)
Title: Home computer system, controls appliances such as TV using digital wireless links
Inventor: GHORI AMAR
IPC: H04L12/28
Filed: 1998-01-30
Abstract: A wireless home computer system includes a computer 405 with a digital wireless transceiver 440.  Computer 405 includes a frame synchronising engine which synchronises audio and visual data prior to transmission.  The transceiver transmits digital data to a home input/output node 415.  The node 415 includes a digital transceiver 490 and input and output devices 495, 494.  The output device may be a television or a stereo system.  The node 415 may also include an encoder for encoding the digital signals it receives from the computer into a television display format.
Patent NZ-332579-A (NZ)
Title: Equipment for taking up hot-rolled material
Inventor: KUWANO HIROAKI
IPC: B21B39/12
Filed: 1998-03-19
Abstract: Hot rolled material take-up equipment which comprises a plurality of take-up machines (24, 26) arranged downstream of a hot finishing rolling mill, a shear (27) provided upstream of pinch rolls (23) of the "upstreammost" take-up machine (24), and a strip threading device (28) provided between the shear and the "upstreammost" pinch rolls for preventing rising of a strip. The strip threading device comprises a guide device for limiting a rising level of the strip or an airflow suction type strip threading device for sucking the strip with an air flow. Also, the plurality of take-up machines comprise down coilers or carousel type reels having two take-up drums (not shown).
Patent NZ-335001-A (NZ)
Title: Genes encoding proteins having transglycosylation activity from UDP-glucose for the 5-position of flavonoids
Inventor: MIZUTANI MASAKO
IPC: C12N15/54
Filed: 1998-07-16
Abstract: Genes encoding for proteins having activity that transfers a glycoside to the 5 position of a flavonoid.
Patent NZ-336413-A (NZ)
Title: Method of generating random numbers by manipulating electronic pointer with coordinates at points corresponding to time instants being used for selection of points subset and computation of number function
Inventor: RAIKE WILLIAM MICHAEL
IPC: H04L9/08
Filed: 1994-12-01
Abstract: n electronic pointer device whose state at time t can be described as a point Xt being (Xt1, Xt2, ... Xtn) is manipulated.  Points Xt representing states of the device of times t = 1, 2, ... n.  A subset of these points is selected and a numerical function of coordinates thus selected is computed.  The desired random number is produced as the binary digits which represent the value of the computed numerical function. 1.	Manipulating an electronic pointer device whose state at any time t can be described as a point represented by coordinates. 2.	The point is measured at consecutive time instants. 3.	A subset of the measured points is selected corresponding to a subset of the time instants. 4.  A numeric function of the coordinates of selected points is computed.
Patent NZ-501200-A (NZ)
Title: Reciprocating diaphragm pump with packless piston-cylinder unit
Inventor: HUNKLINGER HERBERT
IPC: F04B53/12
Filed: 1998-05-12
Abstract: The disclosure relates to a solution for sealing the piston-cylinder unit (1, 2) of reciprocating diaphragm pumps which ensures that said piston-cylinder unit (1, 2) is permanently and reliably sealed while being stated to be simple to assemble. To this end the invention provides for a piston-cylinder unit (1, 2) which presents virtually no play and which is sealed by hydrodynamically sealing the slot (3).
Patent NZ-509662-A (NZ)
Title: Oxygen scavenging packaging
Inventor: JERDEE GARY D
IPC: B65D5/08
Filed: 1999-08-18
Abstract: Use of an oxygen scavenging polymer in packaging material, whereby the material consists of a paperboard substrate having a first polymer layer coated on the outer surface and an inner layer comprising a sandwich layer of an oxygen barrier layer and n oxygen scavenging layer, said scavenging layer comprising an oxygen scavenging polymer that consists of a polymeric backbone with linked cyclic olefinic pendant groups. Also disclosed is the use of the packaging material to decrease oxidation and degradation of its packaged products.
Patent NZ-511576-A (NZ)
Title: Methods of treatment of cardiac arrhythmia
Inventor: BERGERON RAYMOND J
IPC: A61K31/132
Filed: 1998-06-03
Abstract: A method of treating cardiac arrhythmia comprising administering to a non-human patient in need thereof an effective anti-arrhythmic amount of at least one compound having one of Formula (I) or (II); wherein R and R' may be the same or different and are H, alkyl, fluoroalkyl or aralkyl having from 1 to 12 carbon atoms; R1-R4 may be the same or different and are H, R or R'; m and n may be the same or different and are integers from 2 to 10 inclusive; and x, y and z may be the same or different and are integers from 0 to 8, inclusive; or a pharmaceutically acceptable salt of (I) or (II). (62) Divided Out of 501492
Patent NZ-513547-A (NZ)
Title: Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)
Inventor: SMITH ROBIN
IPC: C07F9/54
Filed: 2001-08-13
Abstract: Described is a method of synthesis of a compound with a moiety or the moiety of formula (II) (and/or its quinone form) where n is an integer from 6 to 40 that comprises or includes the preparation or obtaining of a compound of formula (I) (and/or its quinol form) and the subsequent reaction of the compound of formula (I) in the presence of Ph3PHX and Ph3P, where X is a halogen atom selected from Br, I and Cl.
Patent NZ-513561-A (NZ)
Title: Pyridopyranoazepine derivatives, preparation and therapeutic use
Inventor: GALLI FREDERIC
IPC: C07D221/00
Filed: 2000-03-01
Abstract: Compounds of (I) wherein: R1 represents a hydrogen atom, an alkyl, phenylalkyl, phenylhydroxyalkyl, furanylalkyl or furanylhydroxyalkyl group; R2 represents either a hydrogen or a halogen atom or a trifluoromethyl, cyano, hydroxyl, nitro, acetyl, alkyl, alkoxy, or a group of formula NR4R5 wherein: R4 represents a hydrogen atom, alkyl, or alkanoyl, and R5 represents is a hydrogen atom or an alkyl group; or R4 and R5  form, with the nitrogen atom which carries them, a C4-C7 ring, or a phenyl or naphthyl group optionally substituted by a halogen atom or a trifluoromethyl, trifluoromethoxy, cyano, hydroxyl, nitro, acetyl, alkyl, alkoxy or methylenedioxy group linked in the 2 and 3 or 3 and 4 positions of the phenyl ring, or phenyl; R3 represents a hydrogen or halogen atom or an alkyl group.
Patent NZ-514075-A (NZ)
Title: Structural system of torsion/toroidal elements and methods of construction therewith
Inventor: PROVITOLA ANTHONY I
IPC: E04B1/32
Filed: 2000-03-20
Abstract: The present invention is a structural system of torsion/toroidal elements that can be connected to form structures with greater structural strength and efficiency, and which have the capacity to bear compression, tension and flexion loading by conversion of such loading to torsion loading of the connected torsion/toroidal elements. The present invention also includes method of construction using torsion/toroidal elements.
Patent NZ-514453-A (NZ)
Title: Novel sulfonamide compounds and uses thereof
Inventor: SMITH DAVID W
IPC: C07C323/41
Filed: 2000-02-22
Abstract: A compound having the structure shown in formula I and pharmaceutically acceptable salts thereof, wherein:  D is hydrogen, substituted or unsubstituted hydrocarbyl, substituted or unsubstituted heterocycle optionally having one or more double bonds, halogen, alkoxyl, ester, amide, or D and G, taken together, form a substituted or unsubstituted cyclic moiety; and E, is hydrogen, substituted or unsubstituted hydrocarbyl, substituted or unsubstituted heterocycle optionally having one or more double bonds, alkoxyl, amide, sulfonyl, sulfonamidyl, sulfide or alkoxyl; or J and E, taken together, form a substituted or unsubstituted cyclic moiety; and G, when not part of a cyclic moiety including D, is substituted or unsubstituted hydrocarbyl, substituted or unsubstituted heterocycle optionally having one or more double bonds, amine, amide, ester, ether or carbamate; or J, when not part of a cyclic moiety including E, is substituted or unsubstituted hydrocarbyl, heterocycle optionally having one or more double bonds.
Patent NZ-515658-A (NZ)
Title: ID card with optical window data storage.
Inventor: TOOP ANTHONY CHARLES EARL
IPC: G06K21/04
Filed: 2001-11-23
Abstract: A programmable identification card that is substantially flat. The card includes a plurality of windows that can be manually rendered transparent or opaque. The windows are at one end of the card that end being the end inserted into a card reader. The card reader reads the card through sensing and processing the pattern of transmitted or occluded light.
Patent NZ-516016-A (NZ)
Title: New bispidine compounds useful in the treatment of cardiac arrhythmias
Inventor: FRANTSI MARIANNE
IPC: C07D471/08
Filed: 2000-06-15
Abstract: A compound of formula I, wherein; R1 represents optionally substituted alkyl, alkyl-aryl or aryl het; X represents O or S; R5a and R5b independently represent H or alkyl; R2 and R3 are H, optionally substituted alkyl, OR7, N(R7a)R7B, OC(O)R8 or together form -O-(CH2)2-O-, -(CH2)3-, -(CH2)4- or -(CH2)5-; R4 is H or alkyl; R9 represents -C(O)R10, optionally substituted alkyl, alkylaryl or alkylhet2; A represents a single bond, alkylene or optionally substituted -(CH2)C(H)(OR23)(CH2)k; B represents a single bond, alkyene, -(CH2)mN(R24)-, -(CH2)mS(O)n-, or  -(CH2)mO-; and R6 represents one or more optional substituents selected from OH, cyano, halo, amino, nitro and alkyl.
Patent NZ-516025-A (NZ)
Title: Detection of ryanodine receptor antibodies
Inventor: SKEIE GEIR OLVE
IPC: G01N33/68
Filed: 2000-06-08
Abstract: The present invention describes methods, kits and compositions for the detection of ryanodine receptor antibodies in patient serum samples with the aid of N- terminal fragments of the receptor. The invention also describes a method for the manufacture of a pharmaceutical agent comprising such fragments for the prevention and/or treatment of the disease myasthenia gravis, and a method of myasthenia gravis prognosis.
Patent NZ-516101-A (NZ)
Title: Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
Inventor: HORROBIN DAVID FREDERICK
IPC: A61P25/28
Filed: 2000-07-11
Abstract: A formulation containing one or more essential fatty acids (EFAs) from the n-3 and n-6 series of fatty acids, together with one or more homocysteine-lowering agents selected from: vitamin B12, folic acid, a compound related to folic acid with similar biological properties, or vitamin B6; for pharmaceutical or nutritional purposes.
Patent NZ-516669-A (NZ)
Title: Method for ordering goods, services and content over an internetwork using a virtual payment account
Inventor: HUTCHISON ROBIN B
IPC: G06Q30/00
Filed: 2000-06-16
Abstract: A system for purchasing a product comprises a buyer computer operative to purchase a product using a virtual payment account and a seller computer operative to receive a request from the buyer computer to purchase the product from the seller computer using the virtual payment account; in response to the purchase request, determine whether the buyer computer is associated with the virtual payment account; in response to determining that the buyer computer is associated with the virtual payment account, applying a cost of the product to the virtual payment account and provide the product to a buyer associated with the buyer computer. A system for purchasing a product, comprises a buyer computer operative to purchase a product using a virtual payment account; a seller computer operative to receive a request from the buyer computer to purchase the product, the purchase request identifying the virtual payment account as a payment source for the product; and a commerce gateway operative to receive an authentication request from the buyer computer; determine whether the virtual payment account is associated with the buyer computer; transmit an account identification container to the buyer computer in response to determining that the buyer computer is associated with a valid virtual payment account; receive a processed purchase request from the seller computer; determine whether the virtual payment account may be used to pay for the product; in response to determining that the virtual payment account may be used to pay for the product, transmit a valid transaction authorization to the seller computer and charging the virtual payment account for a cost associated with the product.
Patent NZ-525699-A (NZ)
Title: Piperazinylpyrazines compounds as antagonists of serotonin 5-HT2 receptor
Inventor: NILSSON BJORN
IPC: A61P25/28
Filed: 2001-11-20
Abstract: Piperazinylpyrazines compounds of formula (I) that are ligands to the serotonin 5-HT2c receptor and the use of these compounds for the preparation of a medicament which particularly acts on the central nervous system is disclosed, wherein R1, R2, R3, R4, R5, R6 and R7 are as described in the specification.
Patent NZ-526127-A (NZ)
Title: Use of a somatostatin analog in the manufacture of a medicament
Inventor: MOREAU JACQUES-PIERRE
IPC: A61K47/48
Filed: 2000-08-16
Abstract: The somatostatin analogue compound (A) or a pharmaceutically acceptable salt is used in the manufacture of a medicament for the treatment of a disease or condition selected systemic sclerosis, pancreatic pseudocytes, pancreatic ascites, VIPoma, nesidoblastosis, hyperinsulinism, gastrinoma, Zollinger-Ellison Syndrome, scleroderma, postprandial portal venous hypertension, complications of portal hypertension, Cushing's syndrome, gonadotropinoma, hyperparathyroidism, diabetic neuropathy, macular degeneration, hypercalcemia of malignancy, Paget's disease, meningioma, cancer cachexia, psoriasis, hypotension and panic attacks. (62) Divided out of 517646
Patent NZ-526188-A (NZ)
Title: A process for the preparation of iopamidol and the new intermediates therein
Inventor: ANELLI PIER LUCIO
IPC: C07B51/00
Filed: 2001-11-29
Abstract: A process for the preparation of (S)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzendicarboxamide of formula (I) (iopamidol) starting from 5-amino-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,3-benzenedicarboxamide (II) is disclosed, wherein the process comprises a) reacting the compound of formula (II) with a suitable protecting agent, to give a compound of formula (III) wherein R is a group of formula A or B wherein R1 is a hydrogen atom, a C1-C4 straight or branched alkoxy group, R2 is hydrogen, a C1-C4 straight or branched alkoxy group and R3 is a C1-C4 straight or branched alkyl group, a trifuoromethyl or a trichloromethyl group; b) acylating the amino group in position 5 of the intermediate compound of formula (III), by reaction with a (S)-2-(acetyloxy)propanoyl chloride to give a compound of formula (IV) wherein R is as defined above; and c) removing all the acyl groups present in the compound of formula (IV) under basic conditions, with prior cleavage of the cyclic protections of the hydroxy groups in the carboxamido substituents under acidic conditions, when R is a group of formula A carboxamido hydroxy groups under acidic conditions. The formulae referred herein are as shown in the specification.
Patent NZ-536015-A (NZ)
Title: N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, the preparation and their application in therapy
Inventor: DARGAZANLI GIHAD
IPC: A61P25/16
Filed: 2003-04-17
Abstract: Compound in the form of a pure optical isomer (1R,2R) or (1S,2S) or in the form of a threo diastereoisomer, corresponding to general formula (I) are disclosed, wherein: A denotes: a group with formula N-R1 in which R1 denotes a hydrogen atom, an alkyl group, a cycloalkyl group, a phenylalkyl group, an alkenyl group or an alkynyl group; or a group with formula N+(O-)R1 in which R1 is as defined above; or a group with formula N+(R')R1 in which R' denotes an alkyl group and R1 is as defined above; X denotes a hydrogen atom or one or more substituents selected from the halogen atoms and the trifluoromethyl, alkyl and alkoxy groups; R2 denotes a hydrogen atom, one or more substituents selected from the halogen atoms and the trifluoromethyl, alkyl, alkoxy, amino groups with formula NR3R4 in which R3 and R4 each denote a hydrogen atom or an alkyl group or, together with the nitrogen atom bearing same, form a pyrrolidine, piperidine or morpholine ring, or an optionally substituted phenyl group. The compound of formula (I) is suitable for use in therapeutics, particularly for the treatment of behavioural disorders associated with dementia, psychoses, schizophrenia (deficient form and productive form), for the treatment of various forms of anxiety, for the treatment of various forms of depression, including psychotic depression, for the treatment of disorders due to alcohol abuse or to withdrawal from alcohol, sexual behaviour disorders, food intake disorders, and for the treatment of migraine, for the treatment of intense and/or chronic pain, for the treatment of Parkinson's, for the treatment of epilepsy and other epileptic syndromes as a supplement to another antiepileptic treatment.
Patent NZ-536432-A (NZ)
Title: A water-soluble polymer dispersion and a method of producing a water-soluble polymer dispersion
Inventor: STRUCK OLIVER
IPC: C02F11/147
Filed: 2003-05-15
Abstract: Disclosed herein is a water-soluble polymer dispersion comprising: a dispersed polymer made up of: from about 50 to about 99 mole % of at least one water-soluble monomer A and from about 1 to about 50 mole % of at least one water-soluble cationic monomer B; from about 0.05 to about 10 weight % of at least one copolymer as polymer stabiliser C, being a block co-polymer or a random co-polymer; from about 1 to about 25 weight % of at least one cationic polyelectrolyte as co-stabiliser D, relative respectively to the total mass of the dispersion, the mass ratio of stabilisers and co-stabilisers to the dispersed polymer defined by the formula (C+D)/(A+B) is less than 1; and wherein the polymer dispersion has no substantial amount of an inorganic polyvalent anion salt present. A method of producing the water-soluble polymer dispersion and its use in a paper-making process is also disclosed.
Patent NZ-536787-A (NZ)
Title: Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol
Inventor: LABRIE FERNAND
IPC: A61P15/10
Filed: 1999-06-10
Abstract: A pharmaceutical composition comprising a pharmaceutically acceptable diluent or carrier, and a therapeutically effective amount of androst-5-ene-3??,17??-diol or a prodrug thereof in combination with at least one active ingredient selected from the group consisting of dehydrocpiandrosterone, dehydroepiandrosterone-sulfate, and estrogen, wherein any prodrug is an ester or ether prodrug of androst-5-ene-3??,17??-diol which is pharmacologically inactive and which is enzymatically or spontaneously converted in vivo into androst-5-ene-3??,17??-diol, and wherein said pharmaceutical composition is used to treat or reduce the likelihood of acquiring any of the conditions selected from the group consisting of reduced or imbalanced concentrations of sex steroids, symptoms of menopause, vaginal atrophy, hypogonadism, osteoporosis, diminished libido, skin atrophy, skin dryness, urinary incontinence, obesity, cardiovascular disease, atherosclerosis, insulin resistance, loss of memory, and Alzheimers disease.
Patent NZ-537318-A (NZ)
Title: Identifying the batch origin of a compound biological product such as ground mince using genetic profiles
Inventor: SHACKELL GRANT H
IPC: G16B20/40
Filed: 2005-06-17
Abstract: A method for identifying the batch origin of a compound biological product includes the steps of either: (i) obtaining from a reference-sample at least one genetic profile of at least one individual contributor to a batch of compound biological product; or (ii) obtaining from a reference-sample a genetic profile of a compound biological product from a batch wherein the genetic profile of individual contributors may or may not be known. The method further characterised by the steps of: a) recording the genetic profiles from i) or ii) to create reference-sample records and linking these to batch information for the purposes of later identification; b) taking a test-sample of the compound biological product to be identified, c) optionally, obtaining a component-sample by reducing the test-sample into one or more component particles (i.e. individual contributors); d) obtaining at least one genetic profile of either the test-sample at step b) or component-samples at step c); and e) comparing the profile(s) from step d) to the genetic profiles from steps (i) or (ii) of the reference-sample records, for at least one match, so as to identify the batch origin of the compound biological product of the test-sample.
Patent NZ-539351-A (NZ)
Title: A privacy adapter containing a clutch mechanism
Inventor: CONSTANTINOU JOHN
IPC: E05B55/00
Filed: 2005-04-11
Abstract: A lock comprising a clutch mechanism, the clutch mechanism comprising a drive plate and a driven plate, the clutch mechanism being operatively associatable with an outside handle such that when the clutch is engaged, rotation of the outside handle causes rotation of the drive plate and the driven plate, and when the clutch is disengaged, rotation of the outside handle causes rotation only of the drive plate but not the driven plate, an actuator that is movable between a clutch engaging position and the clutch disengaging position, and a button that is on the "inside' of the lock, the button being manually operatable by a person on the inside of the door, the button being operatively associated with the actuator such that operation of the button operate the actuator and therefore engages or disengages the clutch mechanism.